The apoptosis protector, bcl-2 protein, is downregulated in bile duct epithelial cells of human liver allografts

This publication has 32 references indexed in Scilit:

• Immunohistochemical detection of bcl‐2 protein in liver lesions: bcl‐2 protein is expressed in hepatocellular carcinomas but not in liver cell dysplasia
  Histopathology, 1994
• Apoptosis of bile duct epithelial cells in hepatic allograft rejection
  Histopathology, 1994
• BCL‐2 expression in adult and embryonic non‐haematopoietic tissues
  The Journal of Pathology, 1993
• BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.
  Proceedings of the National Academy of Sciences, 1991
• The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation.
  Molecular and Cellular Biology, 1989
• Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
  Nature, 1988
• The bcl-2 gene is rearranged in many diffuse B-cell lymphomas
  Blood, 1988
• Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18.
  Proceedings of the National Academy of Sciences, 1985
• The t(14;18) Chromosome Translocations Involved in B-Cell Neoplasms Result from Mistakes in VDJ Joining
  Science, 1985
• Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around Jh on chromosome 14 and near a transcriptional unit on 18
  Cell, 1985